Source: Annual Congress 2002 - Lung cancer: treatment
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
P. Schneider, S. Kampfer, T. Foitzik, H. J. Buhr (Berlin, Germany). Chemoembolization of the lung improves tumor control in a rat model: first experimental results. Eur Respir J 2002; 20: Suppl. 38, 2540

Member's Comments

No comment yet.

Related content which might interest you: Effect of Nintedanib in a rat model of bleomycin-induced lung fibrosis: a transcriptome analysis Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease Year: 2019 Interferon-γ pretreated human MSC show improved efficiency in humanized mice model of pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment I Year: 2016 Splenectomy inhibits tumor development and metastases in murine lung cancer models Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 In vivo micro-imaging of apoptosis in a murine xenograft model of human lung adenocarcinoma Source: International Congress 2014 – Thoracic tumours: news from the lab Year: 2014 Formation of tumor fragment spheroids (TFS) from lung cancer, in vitro model as like in vivo Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Small cell lung cancer Xenografts can be successfully grafted from bronchoscopy derived samples: model for lung cancer translational research Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 An in vivo comparison of two lung function systems Source: Eur Respir J 2005; 26: Suppl. 49, 177s Year: 2005 The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Anti-endocan antibodies reduces tumor growth in a mouse subcutaneous xenograft model Source: Eur Respir J 2004; 24: Suppl. 48, 704s Year: 2004 Simultaneous inhibition of CTGF and Autotaxin reduces lung fibrosis and improves lung function in mice Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021 SERCA2a gene therapy ameliorates pulmonary hypertension in a pig model: comparison of different delivery methods and therapeutic effect Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Roles of polarized neutrophils on lung tumour development in an orthotopic lung tumour mouse model Source: Annual Congress 2013 –Basic research on lung cancer Year: 2013 Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016 Year: 2017 Correlation of Nintedanib efficacy on fibrotic lesion deposition and lung function within a rat IPF model Source: International Congress 2017 – Lung fibrosis: basic science Year: 2017 A novel ex vivo model for the evaluation of hypoxic adaptation in non-small cell lung cancer using surgery explants Source: Annual Congress 2009 - Lung cancer biology Year: 2009 Introduction of a new preservation solution in an experimental lung transplantation model Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 Aerosol delivery of chemotherapy in an orthotopic model of lung cancer Source: Annual Congress 2005 - Chemotherapy and palliative care Year: 2005 Lung function measurements in mouse models of lung disease: What to expect from FEV0.1? Source: International Congress 2016 – Functional assessment of the airways Year: 2016 The murine orthotopic single lung transplantation model for chronic rejection: work in progress? Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction Year: 2018